Literature DB >> 10815871

Treatment of severe psoriasis with anti-CD25 monoclonal antibodies.

U Mrowietz, K Zhu, E Christophers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815871     DOI: 10.1001/archderm.136.5.675

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  7 in total

1.  [Psoriasis therapy with biologicals].

Authors:  U Mrowietz
Journal:  Hautarzt       Date:  2003-02-11       Impact factor: 0.751

2.  Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.

Authors:  Hideaki Sugiyama; Rolland Gyulai; Eiko Toichi; Edina Garaczi; Shinji Shimada; Seth R Stevens; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

Review 3.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

Review 4.  Psoriasis and the new biologic agents: interrupting a T-AP dance.

Authors:  Scott R A Walsh; Neil H Shear
Journal:  CMAJ       Date:  2004-06-22       Impact factor: 8.262

5.  Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III).

Authors:  Aristo Vojdani; Jonathan Erde
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-05       Impact factor: 2.629

6.  Novel immunobiologics for psoriasis.

Authors:  Nilanjan Ghosh; P N Singh; Vikas Kumar
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

7.  Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis.

Authors:  A M G Langewouters; P E J van Erp; E M G J de Jong; P C M van de Kerkhof
Journal:  Arch Dermatol Res       Date:  2007-12-19       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.